Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
RTIOXA-43
Cat. No.:
OB0425LY-189
Appearance:
Solid
Purity:
99.94%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
RTIOXA-43 is a orexin receptor agonist has a role in regulating neurotransmitters or signaling.
Synonyms:
RTIOXA-43; 2832067-72-6; RTIOXA 43; RTIOXA43
CAS No.:
2832067-72-6
Compound CID:
166625259
Formula:
C37H37N5O5S
Formula Weight:
663.79
Specification
Target:
Orexin receptor (OX receptor)
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
RTIOXA-43 plays a role in anti-obesity research.
